Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Gerhard Prante of Cibus Inc. sold 1,150 shares of Class A Common Stock at $4.35 per share on December 11, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Gerhard Prante, a director at Cibus Inc., sold 1,150 shares of Class A Common Stock on December 11, 2024.
- The sale was executed at a price of $4.35 per share.
- This transaction was conducted under a pre-established Rule 10b5-1 trading plan.
- Following the sale, Prante beneficially owns 58,307 shares of Cibus Inc. stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of a stock sale by a director under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Industry Context
This is a routine disclosure of an insider transaction, which is common for publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among corporate insiders to manage their stock sales and avoid potential insider trading issues.
- Many directors and officers at publicly traded companies, such as those in the S&P 500, utilize similar plans to sell their shares periodically.
- The volume of shares sold is relatively small compared to the total outstanding shares of the company, which is typical for these types of transactions.
Stakeholder Impact
- The sale of shares by a director may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the stock price given the small volume and pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date the Rule 10b5-1 trading plan was adopted by Gerhard Prante. |
| 12/11/2024 | Date of the stock sale transaction. |
| 12/12/2024 | Date the Form 4 was signed. |
Keywords
Cibus Inc., Gerhard Prante, insider trading, Form 4, Rule 10b5-1, stock sale, director, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.